Ma Y - Search Results

1

Screening and molecular docking verification of feature genes related to phospholipid metabolism in hepatocarcinoma caused by hepatitis B.

Zhang J, Zhang F, Zhang L, Zhang M, Liu S, Ma Y. Zhang J, et al. Among authors: ma y. Lipids Health Dis. 2024 Aug 24;23(1):268. doi: 10.1186/s12944-024-02253-3. Lipids Health Dis. 2024. PMID: 39182089 Free PMC article.

2

Setmelanotide optimization through fragment-growing, molecular docking in-silico method targeting MC4 receptor.

Jia X, Fan S, Dong W, Li S, Zhang Y, Ma Y, Wang S. Jia X, et al. Among authors: ma y. J Biomol Struct Dyn. 2023;41(24):15411-15420. doi: 10.1080/07391102.2023.2204385. Epub 2023 Apr 26. J Biomol Struct Dyn. 2023. PMID: 37126536

3

The design of novel inhibitors for treating cancer by targeting CDC25B through disruption of CDC25B-CDK2/Cyclin A interaction using computational approaches.

Li HL, Ma Y, Ma Y, Li Y, Chen XB, Dong WL, Wang RL. Li HL, et al. Among authors: ma y. Oncotarget. 2017 May 16;8(20):33225-33240. doi: 10.18632/oncotarget.16600. Oncotarget. 2017. PMID: 28402259 Free PMC article.

4

Dedifferentiation of Epithelial Cells Incorporates Immune Reprogramming.

Ma Y, Hao J. Ma Y, et al. Trends Cell Biol. 2021 Apr;31(4):237-240. doi: 10.1016/j.tcb.2021.01.007. Epub 2021 Feb 13. Trends Cell Biol. 2021. PMID: 33593679

5

3D QSAR Pharmacophore Based Virtual Screening for Identification of Potential Inhibitors for CDC25B.

Ma Y, Li HL, Chen XB, Jin WY, Zhou H, Ma Y, Wang RL. Ma Y, et al. Comput Biol Chem. 2018 Apr;73:1-12. doi: 10.1016/j.compbiolchem.2018.01.005. Epub 2018 Jan 31. Comput Biol Chem. 2018. PMID: 29413811

6

Zhang J, Li X, Lu Y, Wang G, Ma Y. Zhang J, et al. Among authors: ma y. Cancers (Basel). 2023 Jun 11;15(12):3146. doi: 10.3390/cancers15123146. Cancers (Basel). 2023. PMID: 37370756 Free PMC article.

7

Exploring the mechanism of C473D mutation on CDC25B causing weak binding affinity with CDK2/CyclinA by molecular dynamics study.

Li LP, Li HX, Zhou H, Li WY, Wang RL, Zhang YC, Ma Y. Li LP, et al. Among authors: ma y. J Biomol Struct Dyn. 2023;41(22):12552-12564. doi: 10.1080/07391102.2023.2166995. Epub 2023 Jan 19. J Biomol Struct Dyn. 2023. PMID: 36655391

8

Prediction of SHP2-E76K binding sites based on molecular dynamics simulation and Markov algorithm.

Zhang SP, Chen LJ, Shi ZL, Li X, Ma Y. Zhang SP, et al. Among authors: ma y. J Biomol Struct Dyn. 2024 Nov 19:1-12. doi: 10.1080/07391102.2024.2431193. Online ahead of print. J Biomol Struct Dyn. 2024. PMID: 39558779

9

Design and synthesis of imidazolidine-2,4-dione derivatives as selective inhibitors by targeting protein tyrosine phosphatase-1B over T-cell protein tyrosine phosphatase.

Ma Y, Sun SX, Cheng XC, Wang SQ, Dong WL, Wang RL, Xu WR. Ma Y, et al. Chem Biol Drug Des. 2013 Nov;82(5):595-602. doi: 10.1111/cbdd.12189. Epub 2013 Aug 21. Chem Biol Drug Des. 2013. PMID: 23848232

10

Asiaticoside Antagonizes Proliferation and Chemotherapeutic Drug Resistance in Hepatocellular Carcinoma (HCC) Cells.

Ma Y, Wen J, Wang J, Wang C, Zhang Y, Zhao L, Li J, Feng X. Ma Y, et al. Med Sci Monit. 2020 Aug 30;26:e924435. doi: 10.12659/MSM.924435. Med Sci Monit. 2020. PMID: 32862187 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43,439 results

Search Page

Filters